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We have shown previously that mitochondrial ROS production is essential to turn growth factor
(GF) removal into cell death. Activated RAF, AKT, Bcl-2 and antioxidants protected equally well
against ROS accumulation and subsequent death. Here we investigated whether protection by
survival signaling and antioxidants utilizes shared or distinct targets. Using serum deprivation
from NIH 3T3 ﬁbroblasts and IL-3 withdrawal from promyeloid 32D cells, we showed that pro-
survival signaling by activated RAF but not AKT prevented the decline in Mcl-1 following
GF abrogation. GF starvation increased levels of Bim in both model systems, which was prevented
by RAF in 32D cells but not in NIH 3T3 ﬁbroblasts. RAF and AKT suppressed activation and
mitochondrial translocation of BAX. Also, antioxidant treatment efﬁciently prevented BAX
activation and death of 32D cells but showed little effect on its mitochondrial translocation. No
signiﬁcant impact of antioxidant treatment on Bim or Mcl-1 expression was observed. ROS
produced during GF abrogation also did not alter the activity of intracellular signaling pathways,
which have been implicated previously in cell killing by pro-oxidants. Together these data
suggest Bcl-2 family proteins as convergence point for RAF and ROS in life and death decisions.
& 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.Introduction
Stress to cells causes production of reactive oxygen species (ROS),
which are causally linked to functional impairment and ﬁnally cell
death. ROS are key factors in the development of many diseases
and pathological conditions ranging from cancer to ischemia–
reperfusion injury [1]. While mitochondrial permeabilization,
release of cytochrome c and ultimately caspase activation and
cell death are usually the endpoint in the response to cellularlsevier Inc.
at (J. Troppmair).
Open access under Cstress, less clear is the nature of events, which initially commit the
cell to death under these conditions [2]. Growth factor (GF)
abrogation provides a simple and elegant model to study pro-
cesses involved in life–death decisions and to test intervention
strategies. While our work suggested the increase in mitochon-
drial ROS levels as a key event in cell death commitment after GF
removal [3], others identiﬁed the degradation of the prosurvival
protein Mcl-1 following phosphorylation by GSK3 as an essential
step during this time period [4]. Our experiments alsoC BY license.
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critical for killing of cells by ROS [3]. Both oncogenic and wild
type C- and B-RAF were able to suppress deregulation of
mitochondrial homeostasis [3]. Apoptosis regulation by RAF is
complex and also has been linked to the upregulation of pro-
survival proteins, the inactivation of pro-apoptotic proteins and
the recruitment of various effectors including PI3K/AKT and NF-κB
[5]. The antioxidant effect of RAF signaling was also conﬁrmed in
melanoma cells carrying a mutant form of B-RAF, which
responded to MEK inhibition with increased ROS production,
which sensitized the cells to killing by BH3 mimetics [6].
Pro-apoptotic effects of ROS may directly damage biomolecules
while lower levels modulate intracellular signaling [1]. Redox stress
also triggers the activation of the intrinsic cell death pathway. Both,
BAX and BAK and an increase in mitochondrial Ca2+ were required
for ROS-induced cell death in MEFs [7]. In our model the use of the
antioxidant N-acetyl-cysteine (NAC) proved equally efﬁcient in
protecting GF-deprived cells from apoptotic cell death as activated
RAF, AKT or the pro-survival protein Bcl-2 [3]. The effects of ROS on
signaling and cell death most frequently have been studied by
exogenously adding pro-oxidants to cells and rarely by following up
endogenously produced ROS. The goal of the work presented here
was to (i) further study the effect of RAF signaling in preventing
apoptotic cell death and excessive mitochondrial ROS levels after GF
removal, and (ii) to identify events during the activation of the
intrinsic cell death pathway, which are subject to the regulation by
ROS. Two cellular models were used in our experiments, 32D cells
and NIH 3T3 cells expressing various forms of activated RAF. The
data presented identify members of the Bcl-2 family as targets for
regulation by RAF and antioxidants. Our work also shows that
endogenously produced ROS have only limited effects on the
activation of intracellular signaling pathways implicated in the
regulation of cell death or survival. Finally, we also ﬁnd no evidence
that the maintenance of low endogenous ROS levels by RAF occurs
via effects on the cellular antioxidant capacity suggesting that RAF
signaling may connect to mitochondrial ROS production.Material and methods
Reagents and antibodies
RAF kinase inhibitor BAY43-9006 (sorafenib, 1397) was purchased
from Axon Medchem BV, Groningen, The Netherlands, the MEK
inhibitor UO126 (V1121) from Promega Corporation, Madison, USA,
and the PI-3 kinase inhibitor LY294002 (440202) from Calbiochem,
Darmstadt, Germany. N-acetyl-cysteine (NAC) and 4-hydroxy-
tamoxifen (OHT) were obtained from Sigma Aldrich, Dorset, UK.
OHT was dissolved in ethanol as solvent, which also was used as a
control in cell assays. Primary antibodies against PARP (9542),
caspase-3 (9662), Bim (2819), phospho-AKT Ser473 (4058), AKT
(4685), phospho-GSK-3α/β Ser21/9 (9331), GSK-3 (9338), BAX
(2772) and phospho-p38 Thr180/Tyr182 (9211) were purchased from
Cell Signaling Technology, Boston, MA, antibodies recognizing
phospho-ERK Thr202/Tyr204 (sc-16982), ERK (sc-94), p38 (sc-535),
JNK (sc-571) and VDAC (sc-8828) were obtained from Santa Cruz
Biotechnology, Santa Cruz, CA, Mcl-1 (600-401-394) from Rockland
Immunochemicals, Gibertsville, PA, phospho-JNK (AF1205) from R&D
systems, Minneapolis, MN, α-tubulin (T5168) from Sigma Aldrich,
Dorset, UK and GAPDH (AM4300) from Ambion, Grand Island, NY.Cell culture and viral infections
Mouse ﬁbroblast cell lines NIH 3T3 WT and NIH 3T3 expressing
constitutively active forms of RAF kinases EHneo/gag-v-RAF [8],
C-RAF S427G [9] or B-RAF V600E [10] (kindly provided by R.
Marais, The Patterson Institute for Cancer Research, The Univer-
sity of Manchester, Manchester, UK) were grown in Dulbecco's
modiﬁed Eagle's medium (DMEM) (PAA Laboratories, Pasching,
Austria) containing 10% fetal calf serum (FCS) (PAA Laboratories,
Pasching, Austria), 200 mM L-glutamine and penicillin (100 U/ml)
streptomycin (100 mg/ml) (PAA Laboratories, Pasching, Austria).
Promyeloid interleukin-3 (IL-3)-dependent 32D WT cells were
cultivated in RPMI medium (PAA Laboratories, Pasching, Austria)
containing 10% WEHI 3B conditioned medium as source of IL-3,
10% (FCS) (PAA Laboratories, Pasching, Austria), 200 mM L-gluta-
mine, penicillin (100 U/ml) streptomycin (100 mg/ml) (PAA
Laboratories, Pasching, Austria).
To generate NIH 3T3 cells carrying active form of AKT and NIH
3T3 or 32D cells expressing 4-hydroxytamoxifen (OHT)-inducible
mutant of C-RAF, ERBXB (11) cells were infected with retroviruses
expressing activated AKT/PKB, pBABE-puro AKTα m/p [11] (kindly
provided by B. Hemmings, FMI, Basel) or pBABE-puro ERBXB [12]
(kindly provided by E. Kerkhoff), respectively. Production of
retroviruses and retroviral infection were performed as described
before [13]. In order to induce ERBXB expression in NIH 3T3 and
32D cells, cells were cultivated in growth or starvation media in
the presence of solvent (ethanol) or 200 nM OHT.GF starvation of cells
To induce starvation of NIH 3T3 ﬁbroblasts, cells were washed 2
times with serum free DMEM and incubated in DMEM containing
0.05% FCS for 12 h. 32D cells were washed 3 times with IL-3 free
RPMI containing 10% FCS, resuspended in IL-3 free 10% FCS RPMI
and incubated for 16 or 24 h. In the experiments employing
application of kinase inhibitors NIH 3T3 cells were restimulated
with 10% serum for 10 min followed by cell collection.Immunobloting
Cells were starved for the indicated times and collected using
trypsin (Sigma Aldrich, Dorset, UK). Cells lysis was performed in
NP-40 buffer (25 mM TRIZMA base, 150 mM NaCl, 10 mM
Na4P2O7, 25 mM β-glycero-phosphate, 10% glycerol, 0.75% NP-40,
25 mM NaF, pH 7.2) containing 1:100 protease inhibitor cocktail
set I (Calbiochem, Darmstadt, Germany). Protein concentration
was determined by using Bio-Rad DC protein assay kit (Bio-Rad,
Hercules, CA, USA). 20 mg of protein was separated on 10% or 12%
polyacrylamide gel and transferred to a nitrocellulose membrane
(Whatman Inc., Dassel, Germany). After blocking the membrane
with 5% skim milk powder (Fluka, Buchs, Switzerland) dissolved
in TBST (50 mM TRIZMA base, 150 mM NaCl, pH 7.5 adjusted with
HCl, 0.1% Tween-20). The membrane was incubated overnight
with appropriate primary antibody prepared according to the
protocol provided by manufacturer. After 3 washing steps with
TBST the membrane was further incubated for 1 h in HRP-
conjugated secondary antibody, diluted in TBST with 5% skim
milk powder, washed with TBST and developed using ECL sub-
strates (Thermo Fisher Scientiﬁc Inc, Rockford, IL).
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3106 NIH 3T3 or 10106 32D cells (500,000 cells/ml) were
seeded on 10 cm2 tissue culture plate. After starvation NIH 3T3
cells were lysed for 30 min in ice-cold CHAPS buffer (150 mM
NaCl, 10 mM HEPES, 1% CHAPS, pH 7.4) containing 1:100 protease
inhibitor cocktail set I (Calbiochem, Darmstadt, Germany) and
collected using the cell scraper. 32D cells were pelleted, washed
once with PBS (PAA Laboratories, Pasching, Austria), resuspended
in ice-cold CHAPS buffer and kept on ice for 30 min. The cells
were further broken up by passing NIH 3T3 cells through 25G and
32D cells through 27G needles for six times. The lysate was spun
down at 16,000g for 10 min at 4 1C and protein concentration was
determined. 650 mg lysate protein were incubated with 2 mg of
6A7 BAX antibody (556467, BD Pharmingen) shaking overnight at
4 1C. The remaining lysate was used as full lysate control. Protein
G Agarose (Roche Diagnostic, Wien, Austria) was added and the
sample was shaken for the next 5 h at 4 1C. The agarose beadsFig. 1 – Oncogenic RAF protects against apoptotic cell death (A–D)
V600E (V600E), NIH 3T3 C-RAF S427G (S427G), (B) NIH 3T3 ERBXB
solvent (OHT), (C) NIH 3T3 pBABE, NIH 3T3 pBABE AKTm/p (AKT) c
lysis and further analysed. (D) 32D ERBXB cells (ERBXB) (þ/ OHT
Protection requires RAF kinase activity, PI3K and MEK (E–G). To a
(F) NIH 3T3 V600E and (G) NIH 3T3 ERBXB ﬁbroblasts (þ/ OHT) w
(solvent), 20 lM BAY43-9006 (BAY), 25 lM UO126 (UO) or 25 lM LY
were lysed and analyzed for the activation of RAF and apoptosis s
(casp3), pERK/ERK and pAKT/AKT. GAPDH protein levels were usedwere washed 3 times with ice-cold CHAPS buffer, combined with
Laemmli sample buffer [14] and boiled at 95 1C for 5 min. The
equal volume of samples was used for immunobloting analysis
with anti-BAX antibody (2772, Cell Signaling).
Mitochondria isolation
To isolate mitochondria 3106 NIH 3T3 cells or 10–15106 32D
cells were seeded on 10 cm tissue culture dish. After starva-
tion NIH 3T3 cells were collected in the isolation buffer
(250 mM saccharose, 10 mM Tris, 0.1 mM EGTA, pH 7.4) using
the cell scraper and spun down for 5 min at 600g at 4 1C. 32D cells
were pelleted and washed once with PBS. Cells were then
resuspended in isolation buffer and transferred to 3 ml glass
homogenizer (Sartorius Mechatronics, Vienna, Austria). Samples
were next homogenized on ice, NIH 3T3 with 40 and 32D
cells with 60 strokes and spun down for 10 min at 600g at 4 1C.
To pellet mitochondrial fraction the collected supernatant. (A) NIH 3T3 WT, NIH 3T3 gag-v-RAF (EHneo), NIH 3T3 B-RAF
(ERBXB) cultured in the presence of 200 nM OHT (+OHT) or its
ells were incubated in 10% or 0.05% FCS media for 12 h prior to
) were cultivated in the presence or absence of IL-3 for 16 h.
ssess the requirement of MEK and PI3K (E) NIH 3T3 EHneo,
ere maintained in 0.05% FCS medium containing either DMSO
294002 (LY) for 12 h. At the end of the treatment period cells
ignaling using antibodies directed against PARP, caspase-3
as a loading control.
E X P E R I M E N T A L C E L L R E S E A R C H 3 1 9 ( 2 0 1 3 ) 2 7 2 8 – 2 7 3 8 2731was centrifuged for 10 min at 7000g at 4 1C. Mitochondria
were washed 3 times with isolation buffer, resuspended
in NP-40 buffer and boiled with sample buffer at 95 1C for
5 min.Total antioxidant capacity
NIH 3T3 and 32D cells, cultivated in full growth medium, were
lysed in NP-40 buffer (25 mM TRIZMA base, 150 mM NaCl, 10 mM
Na4P2O7, 25 mM β-glycero-phosphate, 10% glycerol, 0.75% NP-40,
25 mM NaF, pH 7.2) containing 1:100 protease inhibitor cocktail
set I (Calbiochem, Darmstadt, Germany). Protein concentration
was determined by using a Bio-Rad DC protein assay kit (Bio-Rad,
Hercules, CA, USA). 1 ml of lysate at 1 mg/ml protein concentration
was transferred to quartz cuvette with magnetic stirrer and
placed in a Schimadzu RF-5301PC spectroﬂuorophotometer.
2′,7′-dichloroﬂuorescein diacetate (DCF-DA, Sigma Aldrich, Dor-
set, UK) ﬂuorescent probe was added to obtain 20 mM ﬁnal
concentration. After addition of hydrogen peroxide (H2O2, Sigma
Aldrich, Dorset, UK) to 20 mM ﬁnal concentration changes in the
ﬂuorescence intensity were monitored using Hyper RF software
(Schimadzu, Duisburg, Germany). Data are presented as a mean
value of ﬂuorescence increase per minute.Statistics
All data are presented here as means7standard deviations (SD).
Statistical analysis was performed by using student t test forFig. 2 – RAF/MEK signaling in the regulation of Mcl-1/Bim expressio
cells under conditions of limited GF were studied using the followi
RAF (EHneo), NIH 3T3 B-RAF V600E (V600E), NIH 3T3 C-RAF S427G (
200 nM OHT (+OHT) or its solvent (OHT) and (C) NIH 3T3 pBABE,
0.05% FCS media for 12 h, (D) 32D ERBXB cells (þ/OHT) were cultiv
requirement of MEK or PI3K (E) NIH 3T3 EHneo, (F) NIH 3T3 V600E
in 0.05% FCS medium containing either DMSO (solvent), 20 lM BAY
12 h. These treatments were followed by cell lysis and immunoblot
used as a loading control.comparison between 2 groups. To calculate statistical differences
of multiple groups 2 ways ANOVA followed by the Benferroni post
hoc test was performed. Statistical signiﬁcance was considered at
a p value of r0.05.Results
RAF-controlled steps in the activation of intrinsic cell
death pathway
To study effects of RAF/MEK on the activation of the intrinsic cell
death pathway, various versions of mutant RAF were tested
including the previously studied viral oncogene [3,8,15], the most
frequently occurring V600E mutation in human B-RAF [16] and
the only bona ﬁde oncogenic human C-RAF mutant isolated from
a t-AML patient, C-RAF S427G [9], all of them expressed in NIH
3T3 ﬁbroblasts. We chose this cell model because it allowed us to
study the effects of mutant RAF in an otherwise untransformed
background. NIH 3T3 cells responded to GF abrogation with
increased ROS production. However, the use of antioxidants failed
to delay cell death (data not shown), while oncogenic B- and C-
RAF clearly were cytoprotective. These observations suggest that
the amount of ROS produced was insufﬁcient to trigger cell death
in NIH 3T3 cells. This cell model therefore allowed us to study
survival signaling by RAF in a setting where ROS are not involved
in cell death induction. We also included 32D and NIH 3T3 cells
expressing an OHT-regulated fusion protein of the hormone-
binding domain of the estrogen receptor with the kinase domainn. Changes in Mcl-1 and Bim protein levels in NIH 3T3 and 32D
ng cell models and conditions: (A) NIH 3T3 WT, NIH 3T3 gag-v-
S427G) (B) NIH 3T3 ERBXB (ERBXB) cultured in the presence of
NIH 3T3 pBABE AKTm/p (AKT). Cells were incubated in 10% or
ated in the presence or absence of IL-3 for 16 h. To check for the
and (G) NIH 3T3 ERBXB ﬁbroblasts (þ/ OHT) were maintained
43-9006 (BAY), 25 lM UO126 (UO) or 25 lM LY294002 (LY) for
ing using Mcl-1 and Bim antibodies. GAPDH protein levels were
E X P E R I M E N T A L C E L L R E S E A R C H 3 1 9 ( 2 0 1 3 ) 2 7 2 8 – 2 7 3 82732of C-RAF, referred to as ERBXB [17,18]. Additionally, a comparison
was made with the survival kinase AKT [4]. Apoptosis was
induced in ﬁbroblasts by switching cells to medium containing
0.05% serum or by extensively washing out WEHI 3B-conditioned
medium, which was used as source of IL-3, from 32D cells. All
analyses shown were performed after NIH 3T3 and 32D cells had
been maintained under these conditions for 12 h and 16 h,
respectively. Cell death was analyzed by AnnexinV/PI (data not
shown) staining and at the molecular level by monitoring the
processing of the effector caspase-3 (casp3) and the proteolytic
cleavage of the caspase substrate poly-ADP ribose polymerase
(PARP). All versions of oncogenic RAF efﬁciently delayed the onset
of apoptotic cell death in NIH 3T3 and 32D cells (Fig. 1). In
agreement with previously published data [15], inhibiting
RAF/MEK impaired RAF survival activity (Fig. 1E–G).
In NIH 3T3 cells expressing oncogenic RAF (Fig. 2A) or NIH 3T3
and 32D cells expressing OHT-inducible form of RAF (Fig. 2B, D)
Mcl-1 expression levels were higher in cells growing in the
presence of 10% serum or 10% WEHI 3B-conditioned medium
compared to wild type cells. In both cell models GF removal
resulted in the degradation of Mcl-1, which was signiﬁcantly less
pronounced in cells expressing activated RAF (Fig. 2A, B, and D),
but not in cells expressing activated AKT (Fig. 2C). These ﬁndings
demonstrate that Mcl-1 is stabilized in cells expressing oncogenic
RAF. Inclusion of RAF/MEK or PI3K kinase inhibitors reversed the
RAF effect on Mcl-1 stability (Fig. 2E–G).
Basal Bim levels were increased in cells harboring activated RAF
but not AKT in the presence of GF (Fig. 2A–D). Serum starvation of
NIH 3T3 cells resulted in a modest increase in Bim expression,
which was not prevented by RAF. Additionally, activation of RAFFig. 3 – RAF/MEK signaling in BAX activation. BAX activation was a
3T3 WT, NIH 3T3 gag-v-RAF (EHneo), NIH 3T3 B-RAF V600E (V60
cultivated in the presence of 200 nM OHT (+OHT) or its solvent (
were incubated in 10% or 0.05% FCS media for 12 h, (D) 32D ERBX
of IL-3 for 16 h (E) NIH 3T3 V600E cells were maintained in 0.05
9006 (BAY), 25 lM UO126 (UO) or 25 lM LY294002 (LY) for 12 h,
antibody (clone 6A7).caused a retarded migration of Bim. The requirement of RAF/MEK
but not AKT signaling for this modiﬁcation was shown through
the use of inhibitors (Fig. 2E–G). Expression of activated AKT
failed to prevent the decrease in Mcl-1 protein following serum
removal and the increase in Bim was less pronounced (Fig. 2C).
Bim levels signiﬁcantly increased following GF deprivation in 32D
cells (Fig. 2D). Expression of activated RAF prevented the increase
of Bim expression following IL-3 deprivation in 32D cells (Fig. 2D).
We also tested the effect of inhibiting either RAF/MEK or PI3K
signaling in cells expressing activated RAF (Fig. 2E–G). Blocking
RAF kinase activity through the application of BAY43-9006 (BAY)
in GF starved cells resulted in a dramatic loss of Mcl-1 levels and a
concordant drop in Bim levels as well as the change in its
electrophoretic mobility. MEK inhibition had a moderate effect
on Mcl-1 and only affected Bim mobility but not protein levels.
Inhibiting PI3K decreased Mcl-1 expression in NIH EHneo cells
(Fig. 2E), but showed no effect on Bim expression or mobility.
Similar effects were observed in ﬁbroblasts expressing B-RAF
V600E (Fig. 2F) or ERBXB (Fig. 2G).Regulation of BAX activation and mitochondrial
translocation by RAF signaling
Lysates were prepared from 32D and NIH 3T3 cells undergoing GF
abrogation and activated BAX was immunoprecipitated with the
conformation-speciﬁc antibody 6A7 and detected by the total BAX
antibody. As shown in Fig. 3, presence of oncogenic RAF (Fig. 3A, B,
and D) or AKT (Fig. 3C) prevented BAX activation with similar
efﬁciency. In cells expressing oncogenic B-RAF V600E we also testednayzed in NIH 3T3 and 32D cells upon GF withdrawal. (A) NIH
0E), NIH 3T3 C-RAF S427G (S427G), (B) NIH 3T3 ERBXB
OHT), (C) NIH 3T3 pBABE, NIH 3T3 pBABE AKTm/p (AKT) cells
B cells (þ/ OHT) were cultivated in the presence or absence
% medium containing either DMSO (solvent), 20 lM BAY43-
followed by immunoprecipitation (IP) with speciﬁc BAX
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RAF or MEK partially reverted BAX activation, while PI3K inhibition
had no effect. This ﬁnding is striking since the application of the
inhibitor in this setting completely blocked the phosphorylation of
MEK/ERK and suggests kinase-independent functions for RAF in this
context. Following activation BAX translocates to the mitochondria.
We therefore performed cell fractionation experiment and checked
for the presence of BAX in the mitochondrial fraction. As shown inFig. 4 – Regulation of BAX translocation to the mitochondria.
Changes in the mitochondrial levels of BAX in NIH 3T3 and 32D
cells exposed to GF abrogation were analyzed following the
isolation of mitochondrial fractions of NIH 3T3 WT, (A) NIH
gag-v-RAF (EHneo), (B) NIH 3T3 B-RAF V600E (V600E), (C) NIH
3T3 C-RAF S427G (S427G), (D) NIH 3T3 ERBXB cultured in the
presence of 200 nM OHT (+/ OHT), (E) NIH 3T3 pBABE, NIH
3T3 pBABE AKTm/p (AKT) cells maintained in 10% or 0.05% FCS
medium for 12 h and (F) 32D ERBXB cells (+/ OHT) cultivated
in the presence or absence of IL-3 for 16 h were isolated and
analyzed for BAX protein level. Examination of α-tubulin and
VDAC served as a conﬁrmation for purity of isolated
mitochondria.Fig. 4A–D expression of activated RAF and to a lesser degree
of AKT prevented the translocation of BAX to the mitochondria
following GF removal. Slightly increased mitochondrial BAX
levels were observed in some of the cell lines expressing
activated RAF.
Effects of RAF on mitochondrial membrane potential
Mitochondrial permeability transition constitutes an important
step in life and death decisions. As shown in Fig. 5 activation of
RAF was sufﬁcient to prevent the collapse of the membrane
potential in 32D ERBXB cells (Fig. 5A). Treatment with the
uncoupling agent FCCP served as positive control causing com-
plete collapse of barrier function. The protective effect of RAF
again depended on its kinase activity as well as on its down-
stream effector MEK (Fig. 5B). Again inhibiting PI3K also impaired
RAF function.
Identiﬁcation of steps in the intrinsic cell death pathway
and in intracellular signaling susceptible to the regulation
by ROS
Apoptosis induction by ROS has been studied primarily in
settings, where cells were exposed to exogenously applied
pro-oxidants or agents, which caused excessive ROS production.
In the model of GF abrogation ROS production occurs as a cellular
response to the lack of cellular survival signaling. To study ROS
regulation 32D cells were treated with antioxidant that was
present during GF abrogation. The antioxidant N-acetyl-cysteine
(NAC) treatment prevented caspase-3 and PARP processing
(Fig. 6A). Antioxidant treatment also prevented BAX activation
in 32D cells under the same stress conditions (Fig. 6B), but had
little effect on BAX translocation to the mitochondria (Fig. 6C).
Pro-oxidant treatment of 32D cells growing in full medium
efﬁciently caused apoptosis (data not shown). No signiﬁcant
changes in the expression of Bim or Mcl-1 were observed.
ROS or ROS generating drugs frequently elicit cell death by
activating stress kinase pathways or negatively modulating cell
survival pathways. We thus also checked for the involvement of
key MAPKs and of the PI3K/AKT signaling under cellular stress
and monitored the effects of pro- and anti-oxidants on their
activity/activation. Overall, there are only very limited effects of
the pro-oxidant treatment or the use of antioxidants on intracel-
lular signaling (Fig. 6D). Thus in conclusion we ﬁnd no evidence
that ROS effects are mediated through effects on the activity of
MAPKs pathways. Antioxidant treatment also protected cells from
the dissipation of the mitochondrial membrane potential (ΔΨ)
caused by GF withdrawal (Fig. 6E).
Regulation of total antioxidant capacity by RAF signaling
Published work demonstrated the ability of survival proteins
including RAF, AKT and Bcl-2 to maintain mitochondrial ROS
homeostasis [3]. The use on uncoupling reagents had resulted in a
decrease in mitochondrial ROS levels during GF starvation [3],
suggesting that alterations in mitochondrial ROS levels reﬂected
changes in their production rather than in their detoxiﬁcation. We
also failed to detect differences in the expression of key antiox-
idant systems [3]. To further corroborate these ﬁndings we also
compared parental and cells protected by oncogenic RAF for their
Fig. 5 – Effects of RAF on mitochondrial membrane potential. The effects of RAF signaling on the mitochondrial membrane
potential following GF abrogation were studied in 32D cells expressing an OHT-regulated form of oncogenic RAF after IL-3 removal.
(A) 32D ERBXB cells were cultivated in the medium containing 200 nM OHT (+OHT) or solvent (OHT) in the presence or absence
of IL-3 for 24 h and (B) 32D ERBXB cells (7OHT) incubated in IL-3 free medium containing DMSO, 20 lM BAY43-9006 (BAY), 25 lM
UO126 (UO) or 25 lM LY294002 (LY) were subjected to mitochondrial membrane potential analysis with FACS. As a positive control
for mitochondrial potential dissipation cells were treated with 5 lM FCCP. The graph depicts the percentage of cells gated with
high mitochondrial potential (n¼3, **pr0.01, ***pr0.001).
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cell to withstand pro-oxidant stress. Cell lysates were prepared as
described in the section “Material and methods” and directly
tested for their ability to produce ROS. As shown in Fig. 7A and B
we failed to detect differences resulting from the expression of
oncogenic RAF further supporting the hypothesis that the control
of ROS levels by RAF signaling occurs at the level of their
production.Discussion
Genetic and biochemical evidence as well as the application of
kinase inhibitors for the treatment of human tumors have
provided evidence for the survival function of RAF kinases [5].
The exact mechanisms remain to be deﬁned. Intriguingly our
previous work established a link between the survival activity of
RAF and the ability to maintain mitochondrial ROS and Ca2+
homeostasis [3]. This may be a more general mechanism, as ROS
generation is commonly observed after GF abrogation and other
cellular stresses and their accumulation is also counteracted by
the survival proteins AKT and Bcl-2. Mitochondrial ROS produc-
tion therefore may constitute a common endpoint in cell death
induction.
In the work presented here we wanted to (i) further study the
effect of RAF signaling in preventing apoptotic cell death and
excessive mitochondrial ROS levels after GF removal, and (ii) to
identify events during the activation of the intrinsic cell death
pathway, which are subject to the regulation by ROS. For RAF we
have observed an upregulation of Mcl-1 and Bim in cells expres-
sing activated forms of the kinase, which is further enhanced
following GF removal. This is in contrast to the effects of AKT also
reported previously [4]. Increased Mcl-1 transcription has been
observed before in hematopoietic cells due to the activation of the
RAF/MEK/ERK as well as PI3K/AKT pathway [19,20]. In our
experiments we did not observe any upregulation of Mcl-1
protein in NIH 3T3 ﬁbroblasts expressing active AKT. In contrastto RAF, AKT did not inhibit degradation of Mcl-1 after GF removal.
ERK phosphorylation of human Mcl-1 on Thr-163 has been linked
to increase in its stability and to a slow-down protein turnover
[21], while phosphorylation of Ser-159 by GSK3, activated follow-
ing shutdown of AKT activity after GF removal, targets Mcl-1 for
proteasomal degradation [4]. In contrast to 32D cells, GSK3
phosphorylation was not decreased in NIH 3T3 WT cells upon
GF removal (data not shown) suggesting that in ﬁbroblasts AKT/
GSK3 signaling is not important for the regulation of Mcl-1
stability.
NIH 3T3 ﬁbroblasts carrying active C-RAF and B-RAF kinases
had increased Bim expression in full medium. Moreover, migra-
tion of Bim on SDS-PAGE gels was retarded suggesting post-
translational modiﬁcation. Phosphorylation of Bim by ERK results
in the dissociation of Bim from Mcl-1 or Bcl-2 [22]. Following GF
removal we detected further Bim upregulation but no signs of
apoptosis. High Mcl-1 levels simultaneously present in these cells
may help to sequester pro-apoptotic Bim. Expression of AKT
inhibited Bim upregulation induced by GF removal in NIH 3T3
ﬁbroblasts, which may involve forkhead transcription factors [23].
We also detected upregulation of Bim in 32D cells after IL-3
deprivation, which was suppressed by constitutive or inducible
expression of activated C-RAF. C-RAF also promoted changes in
Bim mobility on SDS-PAGE gels, but it did not induce its
upregulation. The lacking increase in Bim protein after IL-3
abrogation in 32D cells expressing active C-RAF may result in
part from PI3K/AKT signaling and its suppression of Bim expres-
sion. We also did not detect any changes in the protein level of
other Bcl-2 proteins like Puma, Bad, BAK or BAX in NIH 3T3 cells
expressing constitutively active C-RAF EHneo or B-RAF V600E
(data not shown). No changes were also observed in 32D cells
carrying activated C-RAF [3].
Our experiments showed that GF removal resulted in BAX
activation in WT cells, which was prevented by active C-RAF or
B-RAF in NIH 3T3 ﬁbroblasts and C-RAF in 32D cells. We also
detected a striking increase in the mitochondrial content of BAX
protein in NIH 3T3 and 32D control cells after GF deprivation.
Fig. 6 – Regulation of intracellular signaling and cell survival by anti-oxidants. 32D cells were starved in the presence of antioxidant N-
acetyl-cysteine (NAC). 32D WT cells were incubated in full growth medium, IL-3 free medium and in IL-3 free medium containing
20mM NAC for 16 h, followed by (A) PARP and caspase-3 (casp3) cleavage, Mcl-1 and Bim protein expression, (B) BAX activation
detection, (C) BAX mitochondrial protein level examination, (D) intracellular signaling pathways analysis (E) mitochondrial membrane
potential was assessed in 32D ERBXB cultured in the presence of 200 nM OHT (+OHT) or its solvent (OHT) and maintained for 24 h in
media supplemented with IL-3, deprived of IL-3, or deprived of IL-3 containing 20mM NAC (n=3, **pr0.01).
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cells suppressed BAX translocation to the mitochondria. Interest-
ingly, expression of C-RAF S427G in NIH 3T3 cells and ERBXB in
both cell lines maintained in growth medium promoted increase
in mitochondrial BAX protein level. Although in healthy cells BAX
localized mostly in the cytosol, there are studies showing that a
subset of this protein can be loosely attached to the mitochondrial
outer membrane. Bcl-2 protects cells from cell death by the
inhibition of BAX insertion into the mitochondrial outer mem-
brane, but it also increases loose BAX binding to the outer
mitochondrial membrane [24]. We detected upregulation of
Mcl-1 in NIH 3T3 and 32D cells carrying active RAF kinases.
Mcl-1 may bind to BAX and suppress its proapoptotic activity in
these cells. Expression of AKT in NIH 3T3 cells after GF removal
prevented BAX activation in these cells and diminished BAXtranslocation to the mitochondria. AKT was suggested to regulate
BAX by direct phosphorylation and thereby inhibiting its translo-
cation to the mitochondria [25].
It has been shown by us that ROS play an important role
in cell death induction in 32D cells after GF deprivation
[3]. The addition of antioxidant N-acetyl-cysteine (NAC) or
overexpression of manganese superoxide dismutase (MnSOD)
suppressed increase in ROS generation and promoted cell
survival [3]. To deﬁne the events potentially regulated by
endogenously produced ROS in the cells undergoing apoptosis
after GF removal we focused on 32D cells. We observed
inhibition of caspase-3 activation when 32D cells were starved
in the presence of antioxidant NAC resulting in protection
against cell death. Moreover, NAC protected 32D cells from a
decline in the mitochondrial membrane potential following
Fig. 7 – Effect of RAF signaling on the cellular total antioxidant capacity (TAC). (A) NIH 3T3 WT, NIH 3T3 gag-v-RAF (EHneo), NIH 3T3
B-RAF V600E (V600E) and (B) 32D ERBXB cells (+/ OHT) were cultivated for 24 h in the growth media, lysed and subjected to TAC
analysis with spectroﬂuorometer using DCF-DA ﬂuorescent probe upon addition of 20 mM H2O2. Addition of H2O2 to NIH 3T3 WT
and 32D ERBXB (-OHT) cell lysates in the presence of 20 mM NAC served as a negative control for ROS production. The data are
presented as a mean value of changes in the ﬂuorescence per minute (n¼3, *pr0.05, **pr0.01).
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upregulation but suppressed destabilization of Mcl-1 after IL-3
removal. Interestingly, we did not observe activation of BAX in
the presence of NAC in 32D cells under limited GF conditions.
However, BAX was translocated to the mitochondria. Activa-
tion and translocation of BAX have been pointed out as
essential triggers for mitochondrial permeabilization, cyto-
chrome c release and subsequent caspase activation. BAX
may have to be activated ﬁrst prior to translocation to the
mitochondria [26], whereas others proposed that BAX ﬁrst is
inserted into the outer mitochondrial membrane followed by
an activation step [27]. Moreover, the requirement of addi-
tional stimuli, like phosphorylation of BAX at the mitochondria
by mitogen kinase p38 has been demonstrated [28].
Major effects on intracellular signaling have been described for
ROS, in particular following pro-oxidant treatment of cells [29].
However, in our experiments, antioxidants did not prevent
changes induced by GF abrogation in the phosphorylation of
tested kinases in 32D cells. While our results clearly support a role
for ROS in causing cell death, others have seen ROS as a byproduct
of the mitochondrial and cellular collapse. BAX deletion inhibited
ROS burst and cell death in nerve GF (NGF)-deprived neurons
[30]. Other studies demonstrated that BAX presence at the
mitochondria is required for ROS-mediated oxidation of cardioli-
pin and cytochrome c release [31]. Our experiments, however,
suggest that endogenously generated ROS in the mitochondria
after GF deprivation may contribute to BAX activation and loss of
mitochondrial membrane potential in 32D cells thereby promot-
ing caspase activation and cell death.
Prosurvival effects of RAF independent of MEK have been
reported for mitochondrially located active C-RAF, which phos-
phorylates Bad promoting its disassociation from Bcl-2 [32,33].
RAF also has been shown to exhibit antiapoptotic function
independent of its kinase activity, e.g. through binding to apop-
tosis signal-regulating kinase (ASK1), suppressing its proapoptotic
function [34,35]. Moreover, a study using knock in of mutant
C-RAF suggested that MEK kinase activity is not required for
C-RAF in normal mice development and protection againstapoptosis [36]. However, these data require independent con-
ﬁrmation since the mutant used (YY340/341FF) possesses
reduced but detectable kinase activity, has only a moderate effect
on C-RAF kinase activity [37].
In terms of maintaining ROS and Ca2+ homeostasis RAF and
MEK behaved equally in our experiments [3,15]. The data pre-
sented here provide further support to such a regulatory mechan-
ism. The MEK inhibitor UO126 abolished the effect of
constitutively active C-RAF or B-RAF on Mcl-1 stability or Bim
modiﬁcation after GF removal. BAX activation was also detected in
these cells resulting in caspase-3 cleavage. Interestingly, applica-
tion of PI3K inhibitor LY 294002 abolished C-RAF but not B-RAF
antiapoptotic effects, suggesting that C-RAF requires also PI3K
activity for cell death inhibition. One possible explanation is that
C-RAF-induced autocrine secretion of a GF as shown previously
[38].Conclusions
Mitochondrial ROS production is essential to turn growth factor
(GF) removal into cell death, which was prevented equally well by
activated RAF, AKT, Bcl-2 and antioxidants. To investigate whether
protection by survival proteins and antioxidants utilizes shared or
distinct targets, we used serum deprivation from NIH 3T3
ﬁbroblasts and IL-3 withdrawal from promyeloid 32D cells.
Signaling by activated RAF but not AKT prevented the decline in
Mcl-1 following GF abrogation. GF starvation increased levels of
Bim in both model systems, which was prevented by RAF in 32D
cells but not in NIH 3T3 ﬁbroblasts. RAF and AKT suppressed
activation and mitochondrial translocation of BAX. Most impor-
tantly our data show that antioxidants prevented BAX activation
but not mitochondrial translocation and had no signiﬁcant impact
on Bim or Mcl-1 expression. Also ROS produced did not alter the
activity of intracellular signaling pathways. Together these data
suggest that Bcl-2 family proteins are critical for the survival
activity of RAF and antioxidants.
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